[1]
A. Aiello, M. E. Mancuso, A. Colombo, C. Teruzzi, and P. Berto, “Budget impact analysis of extended half-life recombinant factor IX (rFIXFc) in the treatment of haemophilia B”, Grhta, vol. 7, no. 1, pp. 40–49, Jul. 2020.